Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
I notice that your message includes instructions to summarize content, but the actual content you'd like me to summarize wasn't included in your message. The section after "This is the information for you to summarize:" appears to be empty.
Could you paste the text you'd like me to work with? Once I have it, I'll provide the summary following your specifications:
Genetic counseling for ALPL gene carriers focuses on understanding how variations in the ALPL gene can lead to hypophosphatasia and what this means for family planning. Genetic counselors help couples assess their chances of having a child affected by a genetic condition and guide them through next steps. Below, you’ll find a step-by-step overview of how transmission probabilities are calculated and what options are available afterward.
Genetic counselors begin by collecting detailed personal and family health histories to identify patterns that may point to hypophosphatasia or other genetic conditions:
This initial information helps estimate the prior probability that each partner carries a disease-causing ALPL variant.
If family history or certain clinical features raise concern, both partners are offered carrier testing:
Most labs report a “detection rate”—the percentage of known variants that their test can find. A 95% detection rate means there’s still a small residual risk of an undetected variant.
Hypophosphatasia associated with ALPL variants can follow:
If both partners are carriers of a pathogenic ALPL variant:
If one partner carries a dominant pathogenic variant:
Genetic counselors integrate test results, detection rates, and inheritance patterns through these steps:
Example (Autosomal Recessive):
These numbers are illustrative—your counselor will use your exact data.
Once transmission probabilities are clear, couples can consider a range of options. Genetic counselors present unbiased information so you can make the choice that fits your goals and values.
It’s natural to feel concern when discussing genetic risks. To help you stay proactive without undue worry:
This overview is meant to guide and inform, but it doesn’t replace personalized medical advice. You should speak to a doctor if you experience:
Your healthcare team—including a genetic counselor and a physician—can clarify test results, refine risk estimates, and plan any needed follow-up.
Working closely with a genetic counselor and your physician ensures you have the clearest picture possible as you plan for the future.
(References)
* Okamura H. Cancer genetic counseling and psycho-oncology. Jpn J Clin Oncol. 1998 Aug;28(8):461-2. doi: 10.1093/jjco/28.8.461. PMID: 9769778.
* Petersen GM. Genetic testing. Hematol Oncol Clin North Am. 2000 Aug;14(4):939-52. doi: 10.1016/s0889-8588(05)70320-8. PMID: 10949782.
* Pina-Neto JM. Genetic counseling. J Pediatr (Rio J). 2008 Aug;84(4 Suppl):S20-6. doi: 10.2223/JPED.1782. Epub 2008 Sep 16. PMID: 18791650.
* Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL, Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015 Jan;17(1):70-87. doi: 10.1038/gim.2014.147. Epub 2014 Nov 13. PMID: 25394175.
* Murphy SL, Anderson JH, Kapplinger JD, Kruisselbrink TM, Gersh BJ, Ommen SR, Ackerman MJ, Bos JM. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy. J Cardiovasc Transl Res. 2016 Apr;9(2):153-61. doi: 10.1007/s12265-016-9681-5. Epub 2016 Feb 25. PMID: 26914223; PMCID: PMC4907543.
* Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol. 2017 Mar;129(3):e41-e55. doi: 10.1097/AOG.0000000000001952. PMID: 28225426.
* Peay HL. Genetic Risk Assessment in Psychiatry. Cold Spring Harb Perspect Med. 2020 Dec 1;10(12). doi: 10.1101/cshperspect.a036616. Epub 2020 Dec 1. PMID: 31570376; PMCID: PMC7706580.
* Masood S. Breast cancer risk assessment and management. Breast J. 2020 Aug;26(8):1505. doi: 10.1111/tbj.14013. Epub 2020 Aug 11. PMID: 32783316.
* Stewart BL, Helber H, Bannon SA, Deuitch NT, Ferguson M, Fiala E, Hamilton KV, Malcolmson J, Pencheva B, Smith-Simmer K. Risk assessment and genetic counseling for hematologic malignancies-Practice resource of the National Society of Genetic Counselors. J Genet Couns. 2025 Apr;34(2):e1959. doi: 10.1002/jgc4.1959. Epub 2024 Aug 27. PMID: 39189353.
* Cheng HH, Giri VN, Goggins M, Yurgelun MB, Karlan BY, Norquist BS, Daly MB, Pal T, AlHilli Z, Arun B, Churpek J, Colonna S, Domchek SM, Escobar MR, Fejerman L, Friedman S, Hagemann A, Hendrix A, Huo D, Hutton ML, Kassem N, Khan S, Kurian AW, Laronga C, Mak JS, Maxwell KN, McDonnell K, Merajver SD, Mersch J, Offit K, Plichta J, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Welborn J, Wick MJ, Wood M, Darlow S, Diwan Z, Dwyer M. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Canc Netw. 2026 Feb;24(2):2-10. doi: 10.6004/jnccn.2026.0007. PMID: 41671423.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.